Upexi, Inc. (UPXI)
$1.08-0.92%Close
SELLRECOVERY · day 27
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV5.2%–465.0%
- Market cap
- $79M
- Beta
- -0.23
- P/E (TTM)
- -0.29
- IV-%ile
- 94
- IV ATM
- 302.9%
- Short % float
- 20.60%
- Days to cover
- 2.2
- SI change
- -18.0%
- 1W
- -5.26%
- 1M
- -1.82%
- vs SPY 1W
- -5.12%
- vs SPY 1M
- -4.32%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 3
- VALUE
- 0
- GROWTH
- 64
- GARP
- 1
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-136.6%
GROSS88
OP184
NET-984
[VALUATION]
P/E TTM-0.29
P/E FWD-
SECTOR PE21.76
INDUSTRY PE22.00
P/B-1.28
P/FCF-
EV/EBITDA-1.36
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.64
ND/EBITDA-
BETA-0.23
NET INCOME (TTM) < 0
Company news
FAQ
- What is LOPJLB’s current signal on UPXI?
- LOPJLB’s latest quantitative signal on Upexi, Inc. (UPXI) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is UPXI in?
- Upexi, Inc. (UPXI) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Upexi, Inc. (UPXI) do?
- Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its …